6,143
Views
43
CrossRef citations to date
0
Altmetric
Review Articles

Application of nanoparticles in cancer detection by Raman scattering based techniques

, , ORCID Icon, , , , & show all
Article: 1373551 | Received 10 May 2017, Accepted 25 Aug 2017, Published online: 19 Dec 2017

Figures & data

Figure 1. A typical Raman spectrum of a chemical compound and related peaks [Citation10].

Figure 1. A typical Raman spectrum of a chemical compound and related peaks [Citation10].

Figure 2. Schematic of the Raman spectra-imaging system. A 785 nm laser is used to illuminate the NP-stained tissue, creating a submillimeter-diameter laser spot. Raman-scattered photons from illuminated NPs are collected by multimode fibers and transmitted to a customized spectrometer (Andore Holospec®), where they are dispersed onto a cooled deep-depletion spectroscopic CCD. For raster scanning imaging, two axes are controlled through a custom LabVIEW program to translate the tissue sample. (b) A photograph of the raster-scanned tissue-imaging device. (c) A depiction of targeted SERS NPs and Biomarker-targeted surface-enhanced Raman scattering (SERS) nanoparticles (NPs) have been explored as a viable option for targeting and imaging multiple cell-surface  biomarkers of cancer. (d) The Raman spectra of the various SERS NPs used in a related study [Citation31].

Figure 2. Schematic of the Raman spectra-imaging system. A 785 nm laser is used to illuminate the NP-stained tissue, creating a submillimeter-diameter laser spot. Raman-scattered photons from illuminated NPs are collected by multimode fibers and transmitted to a customized spectrometer (Andore Holospec®), where they are dispersed onto a cooled deep-depletion spectroscopic CCD. For raster scanning imaging, two axes are controlled through a custom LabVIEW program to translate the tissue sample. (b) A photograph of the raster-scanned tissue-imaging device. (c) A depiction of targeted SERS NPs and Biomarker-targeted surface-enhanced Raman scattering (SERS) nanoparticles (NPs) have been explored as a viable option for targeting and imaging multiple cell-surface  biomarkers of cancer. (d) The Raman spectra of the various SERS NPs used in a related study [Citation31].

Table 1. Some common nanoparticle structures, targeted cancer markers, and Raman reporters, in cancer detection using SERS.

Figure 3. Schematic illustration of formation of sandwich structure and SERS HOT spot with both SERS tags (anti-CEA/4-ATP/Fe3O4-Au NPs) and SERS – active substrate [Citation41].

Figure 3. Schematic illustration of formation of sandwich structure and SERS HOT spot with both SERS tags (anti-CEA/4-ATP/Fe3O4-Au NPs) and SERS – active substrate [Citation41].

Figure 4. Graph of estimated number of different cancer cases. Breast cancer is by far the highest incident type among females [Citation3].

Figure 4. Graph of estimated number of different cancer cases. Breast cancer is by far the highest incident type among females [Citation3].

Figure 5. (a) Plot showing SERS. (b) Schematic representation shows the synthesis protocol for the formation of GNPOP attached SWCNTs [Citation39].

Figure 5. (a) Plot showing SERS. (b) Schematic representation shows the synthesis protocol for the formation of GNPOP attached SWCNTs [Citation39].

Figure 6. Cancer cell targeting and spectroscopic detection by using antibody-conjugated SERS nanoparticles. (a) Preparation of targeted SERS nanoparticles by using a mixture of SH-PEG and a hetero-functional PEG (SH-PEG-COOH). Covalent conjugation of an EGFR-antibody fragment occurs at the exposed terminal of the hetero-functional PEG. (b) SERS spectra obtained from EGFR-positive cancer cells (Tu686) and from EGFR negative cancer cells (human non-small cell lung carcinoma NCI-H520) together with control data and the standard tag spectrum. All spectra were taken in cell suspension with 785-nm laser excitation and were corrected by subtracting the spectra of nanotag-stained cells by the spectra of unprocessed cells. The Raman reporter molecule is diethylthiatri-carbocyanine (DTTC), and its distinct spectral signatures are indicated by wave numbers (cm–1) [Citation71].

Figure 6. Cancer cell targeting and spectroscopic detection by using antibody-conjugated SERS nanoparticles. (a) Preparation of targeted SERS nanoparticles by using a mixture of SH-PEG and a hetero-functional PEG (SH-PEG-COOH). Covalent conjugation of an EGFR-antibody fragment occurs at the exposed terminal of the hetero-functional PEG. (b) SERS spectra obtained from EGFR-positive cancer cells (Tu686) and from EGFR negative cancer cells (human non-small cell lung carcinoma NCI-H520) together with control data and the standard tag spectrum. All spectra were taken in cell suspension with 785-nm laser excitation and were corrected by subtracting the spectra of nanotag-stained cells by the spectra of unprocessed cells. The Raman reporter molecule is diethylthiatri-carbocyanine (DTTC), and its distinct spectral signatures are indicated by wave numbers (cm–1) [Citation71].